Deciphering the unique mechanism whereby bis-sulfonamido-2-phenylbenzoxazole (PBZ) GroEL/ES inhibitors modulate chaperonin ATPase and client protein folding functions.
Stevens, M., Doud, E., Norambuena, J., Tepper, K., Trindl, C.A., Carpenter, R., Chapman, E., Boyd, J.M., Wells, C., Chen, Q., Johnson, S.M.To be published.

















